Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Helper-like innate lymphoid cells and cancer immunotherapy.

Crinier A, Vivier E, Bléry M.

Semin Immunol. 2019 Feb;41:101274. doi: 10.1016/j.smim.2019.04.002. Epub 2019 May 6. Review.

2.

Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment.

Courau T, Bonnereau J, Chicoteau J, Bottois H, Remark R, Assante Miranda L, Toubert A, Blery M, Aparicio T, Allez M, Le Bourhis L.

J Immunother Cancer. 2019 Mar 14;7(1):74. doi: 10.1186/s40425-019-0553-9.

3.

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.

André P, Denis C, Soulas C, Bourbon-Caillet C, Lopez J, Arnoux T, Bléry M, Bonnafous C, Gauthier L, Morel A, Rossi B, Remark R, Breso V, Bonnet E, Habif G, Guia S, Lalanne AI, Hoffmann C, Lantz O, Fayette J, Boyer-Chammard A, Zerbib R, Dodion P, Ghadially H, Jure-Kunkel M, Morel Y, Herbst R, Narni-Mancinelli E, Cohen RB, Vivier E.

Cell. 2018 Dec 13;175(7):1731-1743.e13. doi: 10.1016/j.cell.2018.10.014. Epub 2018 Nov 29. Review.

4.

NKG2D-MICA Interaction: A Paradigm Shift in Innate Recognition.

Bléry M, Vivier E.

J Immunol. 2018 Apr 1;200(7):2229-2230. doi: 10.4049/jimmunol.1800176. No abstract available.

5.

High mTOR activity is a hallmark of reactive natural killer cells and amplifies early signaling through activating receptors.

Marçais A, Marotel M, Degouve S, Koenig A, Fauteux-Daniel S, Drouillard A, Schlums H, Viel S, Besson L, Allatif O, Bléry M, Vivier E, Bryceson Y, Thaunat O, Walzer T.

Elife. 2017 Sep 6;6. pii: e26423. doi: 10.7554/eLife.26423.

6.

Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells.

Ruggeri L, Urbani E, André P, Mancusi A, Tosti A, Topini F, Bléry M, Animobono L, Romagné F, Wagtmann N, Velardi A.

Haematologica. 2016 May;101(5):626-33. doi: 10.3324/haematol.2015.135301. Epub 2015 Dec 31.

7.

IPH4102, a humanized KIR3DL2 antibody with potent activity against cutaneous T-cell lymphoma.

Marie-Cardine A, Viaud N, Thonnart N, Joly R, Chanteux S, Gauthier L, Bonnafous C, Rossi B, Bléry M, Paturel C, Bensussan A, Bagot M, Sicard H.

Cancer Res. 2014 Nov 1;74(21):6060-70. doi: 10.1158/0008-5472.CAN-14-1456.

8.

Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA.

Almagro JC, Gilliland GL, Breden F, Scott JK, Sok D, Pauthner M, Reichert JM, Helguera G, Andrabi R, Mabry R, Bléry M, Voss JE, Laurén J, Abuqayyas L, Barghorn S, Ben-Jacob E, Crowe JE Jr, Huston JS, Johnston SA, Krauland E, Lund-Johansen F, Marasco WA, Parren PW, Xu KY.

MAbs. 2014 May-Jun;6(3):577-618. doi: 10.4161/mabs.28421. Epub 2014 Mar 3.

9.

Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies.

Kohrt HE, Thielens A, Marabelle A, Sagiv-Barfi I, Sola C, Chanuc F, Fuseri N, Bonnafous C, Czerwinski D, Rajapaksa A, Waller E, Ugolini S, Vivier E, Romagné F, Levy R, Bléry M, André P.

Blood. 2014 Jan 30;123(5):678-86. doi: 10.1182/blood-2013-08-519199. Epub 2013 Dec 10.

10.

NK cells in central nervous system disorders.

Poli A, Kmiecik J, Domingues O, Hentges F, Bléry M, Chekenya M, Boucraut J, Zimmer J.

J Immunol. 2013 Jun 1;190(11):5355-62. doi: 10.4049/jimmunol.1203401. Review.

11.

IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect.

Benson DM Jr, Bakan CE, Zhang S, Collins SM, Liang J, Srivastava S, Hofmeister CC, Efebera Y, Andre P, Romagne F, Bléry M, Bonnafous C, Zhang J, Clever D, Caligiuri MA, Farag SS.

Blood. 2011 Dec 8;118(24):6387-91. doi: 10.1182/blood-2011-06-360255. Epub 2011 Oct 26.

12.

The role of natural killer cells in sepsis.

Chiche L, Forel JM, Thomas G, Farnarier C, Vely F, Bléry M, Papazian L, Vivier E.

J Biomed Biotechnol. 2011;2011:986491. doi: 10.1155/2011/986491. Epub 2011 May 14. Review.

13.

TLR3 and Rig-like receptor on myeloid dendritic cells and Rig-like receptor on human NK cells are both mandatory for production of IFN-gamma in response to double-stranded RNA.

Perrot I, Deauvieau F, Massacrier C, Hughes N, Garrone P, Durand I, Demaria O, Viaud N, Gauthier L, Blery M, Bonnefoy-Berard N, Morel Y, Tschopp J, Alexopoulou L, Trinchieri G, Paturel C, Caux C.

J Immunol. 2010 Aug 15;185(4):2080-8. doi: 10.4049/jimmunol.1000532. Epub 2010 Jul 16.

14.

Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo.

Sola C, André P, Lemmers C, Fuseri N, Bonnafous C, Bléry M, Wagtmann NR, Romagné F, Vivier E, Ugolini S.

Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12879-84. doi: 10.1073/pnas.0901653106. Epub 2009 Jun 26.

15.

[Angioma of the liver on MRI].

Rangheard AS, Menu Y, Bléry M.

Presse Med. 2008 Feb;37(2 Pt 2):360-1. Epub 2007 Jul 5. French. No abstract available.

PMID:
17616328
16.

[Multilevel tuberculous spondylitis].

Lesavre A, Miquel A, Bléry M, Menu Y.

Presse Med. 2007 Dec;36(12 Pt 3):1997-8. Epub 2007 Jul 3. French. No abstract available.

PMID:
17611069
17.

Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46.

Walzer T, Bléry M, Chaix J, Fuseri N, Chasson L, Robbins SH, Jaeger S, André P, Gauthier L, Daniel L, Chemin K, Morel Y, Dalod M, Imbert J, Pierres M, Moretta A, Romagné F, Vivier E.

Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3384-9. Epub 2007 Feb 20.

18.

[Functional cellular imaging: revolution for oncology].

Bléry M.

Presse Med. 2006 Sep;35(9 Pt 2):1329-30. French. No abstract available.

PMID:
16969328
19.

Essential role of membrane cholesterol in accelerated BCR internalization and uncoupling from NF-kappa B in B cell clonal anergy.

Bléry M, Tze L, Miosge LA, Jun JE, Goodnow CC.

J Exp Med. 2006 Jul 10;203(7):1773-83. Epub 2006 Jun 26.

20.

[Hepatocellular carcinoma, appearance on computed tomography].

Rangheard AS, Menu Y, Bléry M.

Presse Med. 2006 Apr;35(4 Pt 2):728-9. French. No abstract available.

PMID:
16614622
21.

[Pigmented villonodular synovitis of the knee].

Miquel A, Lesavre A, Menu Y, Bléry M.

Presse Med. 2006 Jan;35(1 Pt 1):67-8. French. No abstract available.

PMID:
16462669
22.

Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis.

Jun JE, Wilson LE, Vinuesa CG, Lesage S, Blery M, Miosge LA, Cook MC, Kucharska EM, Hara H, Penninger JM, Domashenz H, Hong NA, Glynne RJ, Nelms KA, Goodnow CC.

Immunity. 2003 Jun;18(6):751-62.

23.

Imaging of burned-out testis tumor: five new cases and review of the literature.

Tasu JP, Faye N, Eschwege P, Rocher L, Bléry M.

J Ultrasound Med. 2003 May;22(5):515-21. Review.

PMID:
12751863
25.

Hepatic venous pressure gradients measured by duplex ultrasound.

Tasu JP, Rocher L, PEletier G, Kuoch V, Kulh E, Miquel A, Buffet C, BlEry M.

Clin Radiol. 2002 Aug;57(8):746-52.

PMID:
12169287
26.

Adrenal pheochromocytoma and controlateral myelolipoma.

Rocher L, Youssef N, Tasu JP, Paradis V, Bléry M.

Clin Radiol. 2002 Jun;57(6):535-7. No abstract available.

PMID:
12069476
27.

Inhibition of IgE-mediated mast cell activation by the paired Ig-like receptor PIR-B.

Uehara T, Bléry M, Kang DW, Chen CC, Ho LH, Gartland GL, Liu FT, Vivier E, Cooper MD, Kubagawa H.

J Clin Invest. 2001 Oct;108(7):1041-50.

28.

[Evaluation of plain abdominal radiography prescriptions in a university hospital center].

Tasu JP, Takun K, Rocher L, Livartowski J, Nguyen DT, Miquel A, Spira A, Ellrodt A, Bléry M.

Presse Med. 2001 Jun 30;30(22):1097-101. French.

PMID:
11484400
29.

MR evaluation of factors predicting the development of rotator cuff tears.

Tasu JP, Miquel A, Rocher L, Molina V, Gagey O, Bléry M.

J Comput Assist Tomogr. 2001 Mar-Apr;25(2):159-63.

PMID:
11242207
30.

Images in cardiovascular medicine. Computed tomography and magnetic resonance imaging of left ventricular thrombus.

Tasu JP, Pellerin D, Karila-Cohen D, Delfressy JF, Bléry M.

Circulation. 2001 Jan 16;103(2):e8-9. No abstract available.

PMID:
11208701
31.

[Bilateral Chilaiditi's syndrome].

Locher C, Duclos-Vallée JC, Rocher L, Blery M, Buffet C.

Presse Med. 2000 Oct 21;29(31):1738. French. No abstract available.

PMID:
11094622
32.

[Quiz. Imaging of acute urinary infections in adults. Radiologic findings and strategy for imaging procedures].

Bléry M, Tasu J, Rocher L, Rondeau Y, Miquel A.

J Radiol. 2000 Sep;81(9 Suppl):1037-8. French. No abstract available.

PMID:
10995489
33.

[Imaging of acute urinary infections in adults. Radiologic findings and strategy for imaging procedures].

Bléry M, Tasu J, Rocher L, Rondeau Y, Miquel A.

J Radiol. 2000 Sep;81(9 Suppl):1028-36. French.

PMID:
10995488
34.

Primary malignant lymphoma of the urinary bladder: report of three cases and review of the literature.

Tasu JP, Geffroy D, Rocher L, Eschwege P, Strohl D, Benoit G, Paradis V, Bléry M.

Eur Radiol. 2000;10(8):1261-4.

PMID:
10939486
35.

[Evaluation of radiological medical practice at a hospital during night duty].

Tasu J, Rocher L, Nguyen D, Livartowski J, Miquel A, Rondeau Y, Spira A, Ellrodt A, Bléry M.

J Radiol. 2000 Jul;81(7):787-92. French.

PMID:
10915992
36.

Signaling pathways engaged by NK cell receptors: double concerto for activating receptors, inhibitory receptors and NK cells.

Tomasello E, Bléry M, Vély F, Vivier E.

Semin Immunol. 2000 Apr;12(2):139-47. Review. Erratum in: Semin Immunol 2000 Aug;12(4):417.

PMID:
10764622
37.

MR of inferior vena cava extension of a kidney angiomyolipoma.

Tasu JP, Rocher L, Miquel A, Bléry M, Blanchet P, Benoit G, Paradis V.

Eur Radiol. 2000;10(1):196. No abstract available.

PMID:
10663744
38.

Early signaling via inhibitory and activating NK receptors.

Bléry M, Olcese L, Vivier E.

Hum Immunol. 2000 Jan;61(1):51-64. Review.

PMID:
10658978
39.

Intraluminal duodenal diverticulum: radiological and endoscopic ultrasonography findings of an unusual cause of acute pancreatitis.

Tasu JP, Rocher L, Amouyal P, Lorand I, Rondeau Y, Buffet C, Bléry M.

Eur Radiol. 1999;9(9):1898-900.

PMID:
10602972
40.
41.

[Emphysematous pyelonephritis: apropos of 4 cases].

Rocher L, De Leusse-Vialar A, Tasu JP, Rondeau Y, Miquel A, Bazille A, Eschwege P, Bléry M.

J Radiol. 1999 Mar;80(3):297-302. Review. French.

PMID:
10327337
42.

Gene structure, expression pattern, and biological activity of mouse killer cell activating receptor-associated protein (KARAP)/DAP-12.

Tomasello E, Olcese L, Vély F, Geourgeon C, Bléry M, Moqrich A, Gautheret D, Djabali M, Mattei MG, Vivier E.

J Biol Chem. 1998 Dec 18;273(51):34115-9.

43.

Complications of pancreas transplantation: radiological evaluation.

Eschwege P, Rocher L, Rondeau Y, Micquel SD, Bazille A, Hammoudi Y, Blanchet P, Charpentier B, Blery M, Benoit G.

Transplant Proc. 1998 Sep;30(6):2795. No abstract available.

PMID:
9745567
44.

The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1.

Bléry M, Kubagawa H, Chen CC, Vély F, Cooper MD, Vivier E.

Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2446-51.

45.

[Imaging of prostatic leiomyosarcoma and contribution of MRI].

Antoun H, Leguen O, Vieillefond A, Blanchet P, Bléry M.

J Radiol. 1997 Jun;78(6):453-6. French.

PMID:
9239352
46.

Reconstituted killer cell inhibitory receptors for major histocompatibility complex class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifs.

Bléry M, Delon J, Trautmann A, Cambiaggi A, Olcese L, Biassoni R, Moretta L, Chavrier P, Moretta A, Daëron M, Vivier E.

J Biol Chem. 1997 Apr 4;272(14):8989-96.

47.

Transduction of cytotoxic signals in natural killer cells: a general model of fine tuning between activatory and inhibitory pathways in lymphocytes.

Renard V, Cambiaggi A, Vély F, Bléry M, Olcese L, Olivero S, Bouchet M, Vivier E.

Immunol Rev. 1997 Feb;155:205-21. Review.

PMID:
9059896
48.

[Internet and radiology].

Frouge C, Ruelle C, Sigal R, Bléry M.

J Radiol. 1997 Jan;78(1):21-6. Review. French. No abstract available.

PMID:
9091616
49.

Mammographic pattern due to residual Lipiodol after galactography.

Frouge C, Cazenave A, Pham E, Juras J, Treut AL, Dilhuydy M, Bléry M.

Eur Radiol. 1997;7(2):204-7.

PMID:
9038116
50.

Function of killer cell inhibitory receptors for MHC class I molecules.

Vély F, Olcese L, Bléry M, Vivier E.

Immunol Lett. 1996 Dec;54(2-3):145-50.

PMID:
9052869

Supplemental Content

Support Center